Boston Scientific

We are collaborating with healthcare professionals to help reduce costs, improve outcomes and enhance patients' lives with the most advanced and least invasive rhythm management technologies available.

Delivering Meaningful Innovation

Improving Patient Management Through Personalized Care. Our MR-conditional Resonate™ family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems feature the HeartLogic™ Heart Failure Diagnostic to help physicians improve heart failure (HF) management. These devices also combine SmartCRT™ Technology and industry leading EnduraLife™ Battery Technology to improve patient management.

Redefining Heart Care. We’re dedicated to helping patients live longer, healthier lives with the RHYTHMIA HDx™ Mapping System which provides physicians with the ability to diagnose arrhythmias with greater efficiency, delivers targeted therapy and confidently achieves procedural endpoints in complex substrates.

Pioneering Progressive ICD Therapy. The EMBLEM™ MRI S-ICD System is the first and only MR-conditional subcutaneous implantable defibrillator (S-ICD) that provides protection for patients at risk for sudden cardiac death while avoiding risks and complications associated with transvenous leads.


Follow on social Media
HeartLogic™ Heart Failure Diagnostic: The Power to Do What Others Cannot
Hear the story behind the design of HeartLogic and its potential impact on patient care from the perspectives of clinicians and key experts from Boston Scientific.

HeartLogic Brochure
HeartLogic Data Fact Sheet